Europe Finance Weekly
SEE OTHER BRANDS

Fresh finance and banking news from Europe

Europe Finance Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.

Press releases published on May 8, 2025

Savaria annonce l’acquisition de Western Elevator Ltd.

Savaria annonce l’acquisition de Western Elevator Ltd.

LAVAL, Québec, 08 mai 2025 (GLOBE NEWSWIRE) -- Corporation Savaria (« Savaria ») (TSX : SIS) un chef de file mondial de l’industrie de l’accessibilité, a le plaisir d'annoncer l'acquisition de Western Elevator Ltd. (« Western »), un revendeur d'ascenseurs …

Altimmune Presents New Analyses Predicting High Rates of MASH Resolution on Biopsy following Pemvidutide Treatment at the EASL International Liver Congress™

Altimmune Presents New Analyses Predicting High Rates of MASH Resolution on Biopsy following Pemvidutide Treatment at the EASL International Liver Congress™

GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing next-generation peptide-based therapeutics for liver and cardiometabolic diseases, today announced the …

Intellia Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Company Progress

Intellia Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Company Progress

On track to complete enrollment of the global Phase 3 HAELO study in hereditary angioedema (HAE) in the third quarter of 2025 Dosed first patient in the global Phase 3 MAGNITUDE-2 study evaluating nexiguran ziclumeran (nex-z) in patients with hereditary …

Knight Therapeutics Reports First Quarter 2025 Results

Knight Therapeutics Reports First Quarter 2025 Results

MONTREAL, May 08, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2025. All currency …

Thérapeutique Knight déclare ses résultats du premier trimestre de 2025

Thérapeutique Knight déclare ses résultats du premier trimestre de 2025

MONTRÉAL, 08 mai 2025 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight » ou la « Société »), une société pharmaceutique spécialisée panaméricaine (à l’exclusion des É.-U.), a annoncé aujourd’hui ses résultats financiers pour le premier …

MACOM Reports Fiscal Second Quarter 2025 Financial Results

MACOM Reports Fiscal Second Quarter 2025 Financial Results

LOWELL, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- MACOM Technology Solutions Holdings, Inc. (“MACOM”) (Nasdaq: MTSI), a leading supplier of semiconductor products, today announced its financial results for its fiscal second quarter ended April 4, 2025. …

Cronos Group Reports 2025 First Quarter Results

Cronos Group Reports 2025 First Quarter Results

Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Industry-leading balance sheet with $838 million in …

Dyne Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

Dyne Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

- FDA (CDER) Type C meeting held in May 2025 for DYNE-101 in DM1 and Dyne plans to provide a regulatory update following receipt of meeting minutes - - Registrational Expansion Cohort of ACHIEVE Trial of DYNE-101 in DM1 initiated to support potential …

Kelly Reports First-Quarter 2025 Earnings

Kelly Reports First-Quarter 2025 Earnings

TROY, Mich., May 08, 2025 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading specialty talent solutions provider, today announced results for the first quarter of 2025.   Q1 revenue of $1.16 billion, up 11.5% year-over-year reflecting previously …

Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2025 Financial Results

Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2025 Financial Results

Updated Phase 2 data to be presented at ASCO for vilastobart, a tumor-activated, Fc-enhanced, anti-CTLA-4, in combination with atezolizumab in patients with metastatic microsatellite stable colorectal cancer (MSS CRC) Advancing multiple masked T cell …

Warner Music Group Corp. Reports Results for Fiscal Second Quarter Ended March 31, 2025

Warner Music Group Corp. Reports Results for Fiscal Second Quarter Ended March 31, 2025

Financial Highlights Q2 Performance Driven by Revenue Growth Across Recorded Music and Music Publishing Cost Savings Plans on Track, With Reinvestment Initiatives Accelerating Year-to-Date Operating Cash Flow and Free Cash Flow Increased by 53% and 59%, …

Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update

Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update

Dosing complete in the first two cohorts of INLIGHT trial in obesity of WVE-007 (INHBE siRNA), designed to induce healthy weight loss by reducing fat without impacting muscle; clinical data on track for 2H 2025 Dosing underway in second single dose cohort …

Caliber Announces First Quarter 2025 Earnings Release & Conference Call

Caliber Announces First Quarter 2025 Earnings Release & Conference Call

SCOTTSDALE, Ariz., May 08, 2025 (GLOBE NEWSWIRE) -- Caliber (NASDAQ: CWD), a real estate investor, developer, and manager, today announced that it will release its first quarter 2025 financial results after the close of the market on Thursday, May 15, 2025 …

Inspired Reports First Quarter 2025 Results

Inspired Reports First Quarter 2025 Results

First Quarter Revenue of $60.4 million, driven primarily by record Interactive revenue, up 49% year-over-year First Quarter Net Loss of $0.1 million and Adjusted Net Income of $3.8 million First Quarter Adjusted EBITDA of $18.4 million, up 19% from last …

Dada to Hold Extraordinary General Meeting of Shareholders

Dada to Hold Extraordinary General Meeting of Shareholders

SHANGHAI, China, May 08, 2025 (GLOBE NEWSWIRE) -- Dada Nexus Limited (NASDAQ: DADA, “Dada” or the “Company”), China’s leading local on-demand retail and delivery platform, today announced that it has called an extraordinary general meeting of shareholders …

Vital Farms Reports First Quarter 2025 Financial Results

Vital Farms Reports First Quarter 2025 Financial Results

Record First Quarter Net Revenue of $162.2 Million, Up 9.6% Versus Prior Year Period Reaffirms Fiscal Year 2025 Outlook of $740 Million in Net Revenue and $100 Million in Adjusted EBITDA On Track to Reach $1 Billion Net Revenue Target in 2027 AUSTIN, Texas …

Royalty Pharma Reports First Quarter 2025 Results

Royalty Pharma Reports First Quarter 2025 Results

Portfolio Receipts growth of 17% to $839 million; Royalty Receipts growth of 12% Net cash provided by operating activities of $596 million Raised full year 2025 guidance: Portfolio Receipts expected to be $2,975 to $3,125 million NEW YORK, May 08, 2025 ( …

Biz2Credit's Annual Top 25 Cities for Small Business Report Identifies Worcester, MA as #1

Biz2Credit's Annual Top 25 Cities for Small Business Report Identifies Worcester, MA as #1

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- The 2025 Biz2Credit Top Cities for Small Business Study has identified Worcester, MA, as the top city for small businesses in its annual financial analysis. According to Biz2Credit’s analysis, the other cities in …

UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings

UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings

Revenue of $296.5 million in Q4 and $1,137.8 million in fiscal 2025 Organic revenue grew 7.9% in Q4 and 1.2% in fiscal 2025 Diluted EPS of $4.29 in fiscal 2025; Adjusted fiscal 2025 Diluted EPS of $4.52 grew 7.4% versus adjusted prior year Reduced leverage …

Theriva Biologics anuncia el precio de su oferta pública de 7,5 millones de dólares

Theriva Biologics anuncia el precio de su oferta pública de 7,5 millones de dólares

ROCKVILLE, Maryland, May 08, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), una empresa diversificada de fase clínica que desarrolla terapias diseñadas para tratar el cáncer y enfermedades relacionadas en áreas de gran carencia, ha …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service